Presentation Outcomes of Apixaban vs. Warfarin by Type and Duration of A-Fib; Results from the ARISTOTLE Trial Presenter: Sana M. Al-Khatib May 06, 2013
Presentation Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation Presenter: A.R. Harrington April 05, 2013
Presentation Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial Presenter: Greg C. Flaker October 09, 2012
Presentation Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib Presenter: Renato D. Lopes October 03, 2012
Presentation Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin Presenter: S. Lee July 11, 2012
Presentation Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib Presenter: Corey S. Miller May 03, 2012
Presentation Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA Presenter: Hans-Christoph Diener March 08, 2012
Presentation Apixaban frente a Aspirina en Pacientes con Fibrilación Auricular y Antecedentes de ACV o AIT Presenter: Hans-Christoph Diener March 08, 2012